ID   PMP22_HUMAN             Reviewed;         160 AA.
AC   Q01453; Q8WV01;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   07-APR-2021, entry version 210.
DE   RecName: Full=Peripheral myelin protein 22;
DE            Short=PMP-22;
DE   AltName: Full=Growth arrest-specific protein 3;
DE            Short=GAS-3;
GN   Name=PMP22; Synonyms=GAS3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1303228; DOI=10.1038/ng0692-159;
RA   Patel P.I., Roa B.B., Welcher A.A., Schoener-Scott R., Trask B., Pentao L.,
RA   Snipes G.J., Garcia C.A., Francke U., Shooter E.M., Lupski J.R., Suter U.;
RT   "The gene for the peripheral myelin protein PMP-22 is a candidate for
RT   Charcot-Marie-Tooth disease type 1A.";
RL   Nat. Genet. 1:159-165(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Spinal cord;
RX   PubMed=1497668; DOI=10.1016/0006-291x(92)90820-b;
RA   Hayasaka K., Himoro M., Nanao K., Sato W., Miura M., Uyemura K.,
RA   Takahashi E., Takada G.;
RT   "Isolation and sequence determination of cDNA encoding PMP-22 (PAS-
RT   II/SR13/Gas-3) of human peripheral myelin.";
RL   Biochem. Biophys. Res. Commun. 186:827-831(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT CMT1A PRO-16.
RX   PubMed=1303281; DOI=10.1038/ng1292-288;
RA   Valentijn L.J., Baas F., Wolterman R.A., Hoogendijk J.E.,
RA   van den Bosch N.H.A., Zorn I., Gabreeels-Festen A.A.W.M., de Visser M.,
RA   Bolhuis P.A.;
RT   "Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-
RT   Tooth disease type 1A.";
RL   Nat. Genet. 2:288-291(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8482547; DOI=10.1016/0378-1119(93)90384-f;
RA   Edomi P., Martinotti A., Colombo M.P., Schneider C.;
RT   "Sequence of human GAS3/PMP22 full-length cDNA.";
RL   Gene 126:289-290(1993).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 61-160.
RC   TISSUE=Fetal fibroblast;
RX   PubMed=1303210; DOI=10.1093/hmg/1.5.331;
RA   Martinotti A., Cariani C.T., Melani C., Sozzi G., Spurr N.K.,
RA   Pierotti M.A., Colombo M.P.;
RT   "Isolation and mapping to 17p12-13 of the human homologous of the murine
RT   growth arrest specific Gas-3 gene.";
RL   Hum. Mol. Genet. 1:331-334(1992).
RN   [7]
RP   REVIEW ON CMT1A VARIANTS.
RX   PubMed=7762451; DOI=10.1007/978-1-4757-9062-7_3;
RA   Roa B.B., Lupski J.R.;
RT   "Molecular genetics of Charcot-Marie-Tooth neuropathy.";
RL   Adv. Hum. Genet. 22:117-152(1994).
RN   [8]
RP   REVIEW ON CMT1A VARIANTS.
RX   PubMed=7518101; DOI=10.1016/0168-9525(94)90214-3;
RA   Patel P.I., Lupski J.R.;
RT   "Charcot-Marie-Tooth disease: a new paradigm for the mechanism of inherited
RT   disease.";
RL   Trends Genet. 10:128-133(1994).
RN   [9]
RP   REVIEW ON CMT1A AND DSS VARIANTS.
RX   PubMed=9888385;
RX   DOI=10.1002/(sici)1098-1004(1999)13:1<11::aid-humu2>3.0.co;2-a;
RA   Nelis E., Haites N., van Broeckhoven C.;
RT   "Mutations in the peripheral myelin genes and associated genes in inherited
RT   peripheral neuropathies.";
RL   Hum. Mutat. 13:11-28(1999).
RN   [10]
RP   STRUCTURE BY NMR OF WILD TYPE AND MUTANT PRO-16, SUBCELLULAR LOCATION, AND
RP   TOPOLOGY.
RX   PubMed=21827951; DOI=10.1016/j.str.2011.05.009;
RA   Sakakura M., Hadziselimovic A., Wang Z., Schey K.L., Sanders C.R.;
RT   "Structural basis for the Trembler-J phenotype of Charcot-Marie-Tooth
RT   disease.";
RL   Structure 19:1160-1169(2011).
RN   [11]
RP   VARIANTS DSS LYS-69 AND LEU-72, AND VARIANTS CMT1A CYS-79 AND MET-118.
RX   PubMed=8252046; DOI=10.1038/ng1093-189;
RA   Roa B.B., Garcia C.A., Pentao L., Killian J.M., Trask B.J., Suter U.,
RA   Snipes G.J., Ortiz-Lopez R., Shooter E.M., Patel P.I., Lupski J.R.;
RT   "Evidence for a recessive PMP22 point mutation in Charcot-Marie-Tooth
RT   disease type 1A.";
RL   Nat. Genet. 5:189-194(1993).
RN   [12]
RP   VARIANTS DSS LYS-69 AND LEU-72.
RX   PubMed=8275092; DOI=10.1038/ng1193-269;
RA   Roa B.B., Dyck P.J., Marks H.G., Chance P.F., Lupski J.R.;
RT   "Dejerine-Sottas syndrome associated with point mutation in the peripheral
RT   myelin protein 22 (PMP22) gene.";
RL   Nat. Genet. 5:269-273(1993).
RN   [13]
RP   VARIANT CMT1A CYS-79.
RX   PubMed=8510709; DOI=10.1056/nejm199307083290205;
RA   Roa B.B., Garcia C.A., Suter U., Kulpa D.A., Wise C.A., Mueller J.,
RA   Welcher A.A., Snipes G.J., Shooter E.M., Patel P.I., Lupski J.R.;
RT   "Charcot-Marie-Tooth disease type 1A. Association with a spontaneous point
RT   mutation in the PMP22 gene.";
RL   N. Engl. J. Med. 329:96-101(1993).
RN   [14]
RP   VARIANT CMT1A ARG-105.
RX   PubMed=8615087; DOI=10.1007/bf00318579;
RA   Gabreeels-Festen A.A.W.M., Bolhuis P.A., Hoogendijk J.E., Valentijn L.J.,
RA   Eshuis E.J., Gabreeels F.J.M.;
RT   "Charcot-Marie-Tooth disease type 1A: morphological phenotype of the 17p
RT   duplication versus PMP22 point mutations.";
RL   Acta Neuropathol. 90:645-649(1995).
RN   [15]
RP   VARIANT DSS GLN-12.
RX   PubMed=7728152; DOI=10.1002/humu.1380050110;
RA   Valentijn L.J., Ouvrier R.A., van den Bosch N.H.A., Bolhuis P.A., Baas F.,
RA   Nicholson G.A.;
RT   "Dejerine-Sottas neuropathy is associated with a de novo PMP22 mutation.";
RL   Hum. Mutat. 5:76-80(1995).
RN   [16]
RP   VARIANT DSS LEU-72.
RX   PubMed=7675244; DOI=10.1212/wnl.45.9.1766;
RA   Ionasescu V.V., Ionasescu R., Searby C.C., Neahring R.;
RT   "Dejerine-Sottas disease with de novo dominant point mutation of the PMP22
RT   gene.";
RL   Neurology 45:1766-1767(1995).
RN   [17]
RP   VARIANT CMT1A ARG-93.
RX   PubMed=8777804;
RA   Ohnishi A., Yoshimura T., Kanehisa Y., Fukushima Y.;
RT   "A case of hereditary motor and sensory neuropathy type I with a new type
RT   of peripheral myelin protein (PMP)-22 mutation.";
RL   Rinsho Shinkeigaku 35:788-792(1995).
RN   [18]
RP   VARIANT CMT1A ARG-147.
RX   PubMed=8655153; DOI=10.1007/bf02281883;
RA   Navon R., Seifried B., Gal-On N.S., Sadeh M.;
RT   "A new point mutation affecting the fourth transmembrane domain of PMP22
RT   results in severe de novo Charcot-Marie-Tooth disease.";
RL   Hum. Genet. 97:685-687(1996).
RN   [19]
RP   VARIANT DSS LEU-72.
RX   PubMed=9004143; DOI=10.1136/jmg.33.12.1048;
RA   Ionasescu V.V., Searby C., Greenberg S.A.;
RT   "Dejerine-Sottas disease with sensorineural hearing loss, nystagmus, and
RT   peripheral facial nerve weakness: de novo dominant point mutation of the
RT   PMP22 gene.";
RL   J. Med. Genet. 33:1048-1049(1996).
RN   [20]
RP   VARIANTS DSS TRP-72; ILE-76 AND PRO-80.
RX   PubMed=9055797; DOI=10.1093/brain/120.1.47;
RA   Tyson J., Ellis D., Fairbrother U., King R.H., Muntoni F., Jacobs J.,
RA   Malcolm S., Harding A.E., Thomas P.K.;
RT   "Hereditary demyelinating neuropathy of infancy. A genetically complex
RT   syndrome.";
RL   Brain 120:47-63(1997).
RN   [21]
RP   VARIANT DSS ARG-100.
RX   PubMed=9187667; DOI=10.1007/s004390050442;
RA   Bort S., Nelis E., Timmerman V., Sevilla T., Cruz-Martinez A., Martinez F.,
RA   Millan J.M., Arpa J., Vilchez J.J., Prieto F., van Broeckhoven C.,
RA   Palau F.;
RT   "Mutational analysis of the MPZ, PMP22 and Cx32 genes in patients of
RT   Spanish ancestry with Charcot-Marie-Tooth disease and hereditary neuropathy
RT   with liability to pressure palsies.";
RL   Hum. Genet. 99:746-754(1997).
RN   [22]
RP   VARIANT DSS ASP-150.
RX   PubMed=8995589;
RX   DOI=10.1002/(sici)1097-4598(199701)20:1<97::aid-mus13>3.0.co;2-z;
RA   Ionasescu V.V., Searby C.C., Ionasescu R., Chatkupt S., Patel N.,
RA   Koenigsberger R.;
RT   "Dejerine-Sottas neuropathy in mother and son with same point mutation of
RT   PMP22 gene.";
RL   Muscle Nerve 20:97-99(1997).
RN   [23]
RP   VARIANT MET-118.
RX   PubMed=8988161; DOI=10.1038/ng0197-13;
RA   Nelis E., Holmberg B., Adolfsson R., Holmgren G., van Broeckhoven C.;
RT   "PMP22 Thr(118)Met: recessive CMT1 mutation or polymorphism?";
RL   Nat. Genet. 15:13-14(1997).
RN   [24]
RP   VARIANT CMT1A VAL-107.
RX   PubMed=9040744; DOI=10.1212/wnl.48.2.489;
RA   Marrosu M.G., Vaccargiu S., Marrosu G., Vannelli A., Cianchetti C.,
RA   Muntoni F.;
RT   "A novel point mutation in the peripheral myelin protein 22 (PMP22) gene
RT   associated with Charcot-Marie-Tooth disease type 1A.";
RL   Neurology 48:489-493(1997).
RN   [25]
RP   VARIANTS DSS LEU-72 AND GLU-100.
RX   PubMed=9585367; DOI=10.1002/ana.410430521;
RA   Marques W. Jr., Thomas P.K., Sweeney M.G., Carr L., Wood N.W.;
RT   "Dejerine-Sottas neuropathy and PMP22 point mutations: a new base pair
RT   substitution and a possible 'hot spot' on Ser72.";
RL   Ann. Neurol. 43:680-683(1998).
RN   [26]
RP   VARIANT DSS CYS-150.
RX   PubMed=9544841; DOI=10.1007/s004390050694;
RA   Ikegami T., Ikeda H., Aoyama M., Matsuki T., Imota T., Fukuuchi Y.,
RA   Amano T., Toyoshima I., Ishihara Y., Endoh H., Hayasaka K.;
RT   "Novel mutations of the peripheral myelin protein 22 gene in two pedigrees
RT   with Dejerine-Sottas disease.";
RL   Hum. Genet. 102:294-298(1998).
RN   [27]
RP   VARIANT DSS PRO-79.
RX   PubMed=9452053; DOI=10.1002/humu.1380110132;
RA   Bort S., Sevilla T., Garcia-Planells J., Blesa D., Paricio N.,
RA   Vilchez J.J., Prieto F., Palau F.;
RT   "Dejerine-Sottas neuropathy associated with de novo S79P mutation of the
RT   peripheral myelin protein 22 (PMP22) gene.";
RL   Hum. Mutat. Suppl. 1:S95-S98(1998).
RN   [28]
RP   VARIANT MET-118.
RX   PubMed=9452099; DOI=10.1002/humu.1380110178;
RA   Sorour E., Upadhyaya M.;
RT   "Mutation analysis in Charcot-Marie-Tooth disease type 1 (CMT1).";
RL   Hum. Mutat. Suppl. 1:S242-S247(1998).
RN   [29]
RP   VARIANT DSS PHE-84 DEL.
RX   PubMed=9633821;
RX   DOI=10.1002/(sici)1098-1004(1998)12:1<59::aid-humu9>3.0.co;2-a;
RA   Silander K., Meretoja P., Juvonen V., Ignatius J., Pihko H., Saarinen A.,
RA   Wallden T., Herrgaard E., Aula P., Savontaus M.-L.;
RT   "Spectrum of mutations in Finnish patients with Charcot-Marie-Tooth disease
RT   and related neuropathies.";
RL   Hum. Mutat. 12:59-68(1998).
RN   [30]
RP   VARIANT HNPP MET-30.
RX   PubMed=9748013; DOI=10.1212/wnl.51.3.702;
RA   Sahenk Z., Chen L., Freimer M.;
RT   "A novel PMP22 point mutation causing HNPP phenotype: studies on nerve
RT   xenografts.";
RL   Neurology 51:702-707(1998).
RN   [31]
RP   VARIANT CMT1E PRO-67.
RX   PubMed=10330345; DOI=10.1086/302420;
RA   Kovach M.J., Lin J.-P., Boyadjiev S., Campbell K., Mazzeo L., Herman K.,
RA   Rimer L.A., Frank W., Llewellyn B., Wang Jabs E., Gelber D., Kimonis V.E.;
RT   "A unique point mutation in the PMP22 gene is associated with Charcot-
RT   Marie-Tooth disease and deafness.";
RL   Am. J. Hum. Genet. 64:1580-1593(1999).
RN   [32]
RP   VARIANT DSS TRP-157.
RC   TISSUE=Peripheral blood;
RX   PubMed=10211478;
RX   DOI=10.1002/1531-8249(199904)45:4<518::aid-ana15>3.0.co;2-u;
RA   Parman Y., Plante-Bordeneuve V., Guiochon-Mantel A., Eraksoy M., Said G.;
RT   "Recessive inheritance of a new point mutation of the PMP22 gene in
RT   Dejerine-Sottas disease.";
RL   Ann. Neurol. 45:518-522(1999).
RN   [33]
RP   VARIANT CMT1A VAL-37.
RX   PubMed=10489052; DOI=10.1212/wnl.53.4.846;
RA   Fabrizi G.M., Cavallaro T., Taioli F., Orrico D., Morbin M., Simonati A.,
RA   Rizzuto N.;
RT   "Myelin uncompaction in Charcot-Marie-Tooth neuropathy type 1A with a point
RT   mutation of peripheral myelin protein-22.";
RL   Neurology 53:846-851(1999).
RN   [34]
RP   VARIANT DSS ARG-149.
RX   PubMed=10663978; DOI=10.1007/pl00007446;
RA   Ohnishi A., Yamamoto T., Izawa K., Yamamori S., Takahashi K., Mega H.,
RA   Jinnai K.;
RT   "Dejerine-Sottas disease with a novel de novo dominant mutation, Ser 149
RT   Arg, of the peripheral myelin protein 22.";
RL   Acta Neuropathol. 99:327-330(2000).
RN   [35]
RP   VARIANT GLY-157.
RC   TISSUE=Peripheral blood leukocyte;
RX   PubMed=10632107;
RX   DOI=10.1002/1531-8249(200001)47:1<101::aid-ana16>3.0.co;2-2;
RA   Numakura C., Lin C., Oka N., Akiguchi I., Hayasaka K.;
RT   "Hemizygous mutation of the peripheral myelin protein 22 gene associated
RT   with Charcot-Marie-Tooth disease type 1.";
RL   Ann. Neurol. 47:101-103(2000).
RN   [36]
RP   VARIANT CMT1A LEU-72.
RX   PubMed=11140841; DOI=10.1034/j.1399-0004.2000.580511.x;
RA   Bissar-Tadmouri N., Parman Y., Boutrand L., Deymeer F., Serdaroglu P.,
RA   Vandenberghe A., Battaloglu E.;
RT   "Mutational analysis and genotype/phenotype correlation in Turkish Charcot-
RT   Marie-Tooth type 1 and HNPP patients.";
RL   Clin. Genet. 58:396-402(2000).
RN   [37]
RP   VARIANTS CMT1A 25-VAL-SER-26 DEL AND ARG-147, AND VARIANT MET-118.
RX   PubMed=10737979;
RX   DOI=10.1002/(sici)1098-1004(200004)15:4<340::aid-humu6>3.0.co;2-y;
RA   Mersiyanova I.V., Ismailov S.M., Polyakov A.V., Dadali E.L., Fedotov V.P.,
RA   Nelis E., Loefgren A., Timmerman V., Van Broeckhoven C., Evgrafov O.V.;
RT   "Screening for mutations in the peripheral myelin genes PMP22, MPZ and Cx32
RT   (GJB1) in Russian Charcot-Marie-Tooth neuropathy patients.";
RL   Hum. Mutat. 15:340-347(2000).
RN   [38]
RP   VARIANTS DSS LEU-72 AND ARG-109.
RX   PubMed=11438991; DOI=10.1002/humu.1147;
RA   Mostacciuolo M.L., Righetti E., Zortea M., Bosello V., Schiavon F.,
RA   Vallo L., Merlini L., Siciliano G., Fabrizi G.M., Rizzuto N., Milani M.,
RA   Baratta S., Taroni F.;
RT   "Charcot-Marie-Tooth disease type I and related demyelinating neuropathies:
RT   mutation analysis in a large cohort of Italian families.";
RL   Hum. Mutat. 18:32-41(2001).
RN   [39]
RP   INVOLVEMENT IN IDP.
RX   PubMed=12439896; DOI=10.1002/ajmg.10725;
RA   Korn-Lubetzki I., Argov Z., Raas-Rothschild A., Wirguin I., Steiner I.;
RT   "Family with inflammatory demyelinating polyneuropathy and the HNPP 17p12
RT   deletion.";
RL   Am. J. Med. Genet. 113:275-278(2002).
RN   [40]
RP   VARIANT CMT1E ARG-28, AND VARIANT CMT1A/DSS PRO-71.
RX   PubMed=11835375; DOI=10.1002/ana.10089;
RA   Boerkoel C.F., Takashima H., Garcia C.A., Olney R.K., Johnson J., Berry K.,
RA   Russo P., Kennedy S., Teebi A.S., Scavina M., Williams L.L., Mancias P.,
RA   Butler I.J., Krajewski K., Shy M., Lupski J.R.;
RT   "Charcot-Marie-Tooth disease and related neuropathies: mutation
RT   distribution and genotype-phenotype correlation.";
RL   Ann. Neurol. 51:190-201(2002).
RN   [41]
RP   VARIANT CMT1A LEU-72.
RX   PubMed=12402337; DOI=10.1002/humu.10134;
RA   Numakura C., Lin C., Ikegami T., Guldberg P., Hayasaka K.;
RT   "Molecular analysis in Japanese patients with Charcot-Marie-Tooth disease:
RT   DGGE analysis for PMP22, MPZ, and Cx32/GJB1 mutations.";
RL   Hum. Mutat. 20:392-398(2002).
RN   [42]
RP   VARIANTS DSS PRO-16; ARG-80 AND ARG-105.
RX   PubMed=12090401; DOI=10.1046/j.1469-7580.2002.00043.x;
RA   Gabreeels-Festen A.A.W.M.;
RT   "Dejerine-Sottas syndrome grown to maturity: overview of genetic and
RT   morphological heterogeneity and follow-up of 25 patients.";
RL   J. Anat. 200:341-356(2002).
RN   [43]
RP   VARIANT CMT1A PHE-65.
RX   PubMed=12497641; DOI=10.1002/humu.9101;
RA   Huehne K., Benes V., Thiel C., Kraus C., Kress W., Hoeltzenbein M.,
RA   Ploner C.J., Kotzian J., Reis A., Rott H.D., Rautenstrauss B.W.;
RT   "Novel mutations in the Charcot-Marie-Tooth disease genes PMP22, MPZ, and
RT   GJB1.";
RL   Hum. Mutat. 21:100-100(2003).
RN   [44]
RP   VARIANT CMT1E 115-ALA--THR-118 DEL.
RX   PubMed=12578939; DOI=10.1212/01.wnl.0000044048.27971.fc;
RA   Sambuughin N., de Bantel A., McWilliams S., Sivakumar K.;
RT   "Deafness and CMT disease associated with a novel four amino acid deletion
RT   in the PMP22 gene.";
RL   Neurology 60:506-508(2003).
RN   [45]
RP   VARIANT HNPP THR-67.
RX   PubMed=12796555; DOI=10.1212/01.wnl.0000066049.13848.f2;
RA   Nodera H., Nishimura M., Logigian E.L., Herrmann D.N., Kaji R.;
RT   "HNPP due to a novel missense mutation of the PMP22 gene.";
RL   Neurology 60:1863-1864(2003).
RN   [46]
RP   VARIANT HNPP/CMT1A PHE-22.
RX   PubMed=15205993; DOI=10.1007/s10048-004-0184-1;
RA   Kleopa K.A., Georgiou D.-M., Nicolaou P., Koutsou P., Papathanasiou E.,
RA   Kyriakides T., Christodoulou K.;
RT   "A novel PMP22 mutation Ser22Phe in a family with hereditary neuropathy
RT   with liability to pressure palsies and CMT1A phenotypes.";
RL   Neurogenetics 5:171-175(2004).
RN   [47]
RP   VARIANT CMT1E ARG-23.
RX   PubMed=15099592; DOI=10.1016/j.nmd.2004.02.009;
RA   Joo I.S., Ki C.S., Joo S.Y., Huh K., Kim J.W.;
RT   "A novel point mutation in PMP22 gene associated with a familial case of
RT   Charcot-Marie-Tooth disease type 1A with sensorineural deafness.";
RL   Neuromuscul. Disord. 14:325-328(2004).
RN   [48]
RP   VARIANT CNT1A MET-118.
RX   PubMed=16437560; DOI=10.1002/ana.20777;
RA   Shy M.E., Scavina M.T., Clark A., Krajewski K.M., Li J., Kamholz J.,
RA   Kolodny E., Szigeti K., Fischer R.A., Saifi G.M., Scherer S.S.,
RA   Lupski J.R.;
RT   "T118M PMP22 mutation causes partial loss of function and HNPP-like
RT   neuropathy.";
RL   Ann. Neurol. 59:358-364(2006).
CC   -!- FUNCTION: Might be involved in growth regulation, and in myelinization
CC       in the peripheral nervous system.
CC   -!- INTERACTION:
CC       Q01453; O95236-2: APOL3; NbExp=3; IntAct=EBI-2845982, EBI-11976321;
CC       Q01453; P41181: AQP2; NbExp=3; IntAct=EBI-2845982, EBI-12701138;
CC       Q01453; Q3SXY8: ARL13B; NbExp=3; IntAct=EBI-2845982, EBI-11343438;
CC       Q01453; P07307-3: ASGR2; NbExp=3; IntAct=EBI-2845982, EBI-12808270;
CC       Q01453; O75787: ATP6AP2; NbExp=3; IntAct=EBI-2845982, EBI-2512037;
CC       Q01453; Q6UWD8: C16orf54; NbExp=3; IntAct=EBI-2845982, EBI-18041102;
CC       Q01453; P09693: CD3G; NbExp=3; IntAct=EBI-2845982, EBI-3862428;
CC       Q01453; P19397: CD53; NbExp=3; IntAct=EBI-2845982, EBI-6657396;
CC       Q01453; Q07108: CD69; NbExp=3; IntAct=EBI-2845982, EBI-2836595;
CC       Q01453; P40198: CEACAM3; NbExp=3; IntAct=EBI-2845982, EBI-12851752;
CC       Q01453; P56856: CLDN18; NbExp=3; IntAct=EBI-2845982, EBI-16354902;
CC       Q01453; O00501: CLDN5; NbExp=3; IntAct=EBI-2845982, EBI-18400628;
CC       Q01453; P56747: CLDN6; NbExp=3; IntAct=EBI-2845982, EBI-12955011;
CC       Q01453; Q2HXU8-2: CLEC12B; NbExp=3; IntAct=EBI-2845982, EBI-12811991;
CC       Q01453; Q86T13: CLEC14A; NbExp=3; IntAct=EBI-2845982, EBI-17710733;
CC       Q01453; O43889-2: CREB3; NbExp=3; IntAct=EBI-2845982, EBI-625022;
CC       Q01453; Q96BA8: CREB3L1; NbExp=3; IntAct=EBI-2845982, EBI-6942903;
CC       Q01453; Q15125: EBP; NbExp=3; IntAct=EBI-2845982, EBI-3915253;
CC       Q01453; Q92838: EDA; NbExp=3; IntAct=EBI-2845982, EBI-529425;
CC       Q01453; P54849: EMP1; NbExp=3; IntAct=EBI-2845982, EBI-4319440;
CC       Q01453; Q9Y282: ERGIC3; NbExp=3; IntAct=EBI-2845982, EBI-781551;
CC       Q01453; P60508: ERVFRD-1; NbExp=3; IntAct=EBI-2845982, EBI-17973325;
CC       Q01453; Q5JX71: FAM209A; NbExp=3; IntAct=EBI-2845982, EBI-18304435;
CC       Q01453; P55899: FCGRT; NbExp=3; IntAct=EBI-2845982, EBI-2833934;
CC       Q01453; O15552: FFAR2; NbExp=3; IntAct=EBI-2845982, EBI-2833872;
CC       Q01453; P48165: GJA8; NbExp=3; IntAct=EBI-2845982, EBI-17458373;
CC       Q01453; O15529: GPR42; NbExp=3; IntAct=EBI-2845982, EBI-18076404;
CC       Q01453; Q9BZJ8: GPR61; NbExp=3; IntAct=EBI-2845982, EBI-12808020;
CC       Q01453; Q9NZD1: GPRC5D; NbExp=3; IntAct=EBI-2845982, EBI-13067820;
CC       Q01453; P38484: IFNGR2; NbExp=3; IntAct=EBI-2845982, EBI-3905457;
CC       Q01453; Q8WXH2: JPH3; NbExp=3; IntAct=EBI-2845982, EBI-1055254;
CC       Q01453; P48051: KCNJ6; NbExp=3; IntAct=EBI-2845982, EBI-12017638;
CC       Q01453; O15554: KCNN4; NbExp=3; IntAct=EBI-2845982, EBI-2924473;
CC       Q01453; P26715: KLRC1; NbExp=6; IntAct=EBI-2845982, EBI-9018187;
CC       Q01453; Q9GZW8: MS4A7; NbExp=3; IntAct=EBI-2845982, EBI-721391;
CC       Q01453; P35372-10: OPRM1; NbExp=3; IntAct=EBI-2845982, EBI-12807478;
CC       Q01453; Q13113: PDZK1IP1; NbExp=3; IntAct=EBI-2845982, EBI-716063;
CC       Q01453; O15173: PGRMC2; NbExp=3; IntAct=EBI-2845982, EBI-1050125;
CC       Q01453; Q9H6H4: REEP4; NbExp=3; IntAct=EBI-2845982, EBI-7545592;
CC       Q01453; Q9NY72: SCN3B; NbExp=3; IntAct=EBI-2845982, EBI-17247926;
CC       Q01453; P31431: SDC4; NbExp=3; IntAct=EBI-2845982, EBI-3913237;
CC       Q01453; Q16585: SGCB; NbExp=3; IntAct=EBI-2845982, EBI-5663627;
CC       Q01453; Q3SXP7: SHISAL1; NbExp=3; IntAct=EBI-2845982, EBI-18037857;
CC       Q01453; P54219-3: SLC18A1; NbExp=3; IntAct=EBI-2845982, EBI-17595455;
CC       Q01453; Q9H2H9: SLC38A1; NbExp=3; IntAct=EBI-2845982, EBI-9978441;
CC       Q01453; Q9BZL3: SMIM3; NbExp=9; IntAct=EBI-2845982, EBI-741850;
CC       Q01453; Q9HBV2: SPACA1; NbExp=3; IntAct=EBI-2845982, EBI-17498703;
CC       Q01453; P27105: STOM; NbExp=3; IntAct=EBI-2845982, EBI-1211440;
CC       Q01453; Q8N9I0: SYT2; NbExp=3; IntAct=EBI-2845982, EBI-8032987;
CC       Q01453; Q96MV1: TLCD4; NbExp=3; IntAct=EBI-2845982, EBI-12947623;
CC       Q01453; Q96CE8: TM4SF18; NbExp=3; IntAct=EBI-2845982, EBI-13351685;
CC       Q01453; Q96DZ7: TM4SF19; NbExp=3; IntAct=EBI-2845982, EBI-6448756;
CC       Q01453; Q8IV31: TMEM139; NbExp=3; IntAct=EBI-2845982, EBI-7238458;
CC       Q01453; Q9NUH8: TMEM14B; NbExp=3; IntAct=EBI-2845982, EBI-8638294;
CC       Q01453; Q3MIR4: TMEM30B; NbExp=3; IntAct=EBI-2845982, EBI-9527107;
CC       Q01453; Q96HE8: TMEM80; NbExp=3; IntAct=EBI-2845982, EBI-11742770;
CC       Q01453; Q9H3N1: TMX1; NbExp=3; IntAct=EBI-2845982, EBI-1051115;
CC       Q01453; O95859: TSPAN12; NbExp=3; IntAct=EBI-2845982, EBI-2466403;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:21827951};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:21827951}.
CC   -!- DISEASE: Charcot-Marie-Tooth disease 1A (CMT1A) [MIM:118220]: A
CC       dominant demyelinating form of Charcot-Marie-Tooth disease, a disorder
CC       of the peripheral nervous system, characterized by progressive weakness
CC       and atrophy, initially of the peroneal muscles and later of the distal
CC       muscles of the arms. Charcot-Marie-Tooth disease is classified in two
CC       main groups on the basis of electrophysiologic properties and
CC       histopathology: primary peripheral demyelinating neuropathies
CC       (designated CMT1 when they are dominantly inherited) and primary
CC       peripheral axonal neuropathies (CMT2). Demyelinating neuropathies are
CC       characterized by severely reduced nerve conduction velocities (less
CC       than 38 m/sec), segmental demyelination and remyelination with onion
CC       bulb formations on nerve biopsy, slowly progressive distal muscle
CC       atrophy and weakness, absent deep tendon reflexes, and hollow feet.
CC       {ECO:0000269|PubMed:10489052, ECO:0000269|PubMed:10737979,
CC       ECO:0000269|PubMed:11140841, ECO:0000269|PubMed:11835375,
CC       ECO:0000269|PubMed:12402337, ECO:0000269|PubMed:12497641,
CC       ECO:0000269|PubMed:1303281, ECO:0000269|PubMed:15205993,
CC       ECO:0000269|PubMed:8252046, ECO:0000269|PubMed:8510709,
CC       ECO:0000269|PubMed:8615087, ECO:0000269|PubMed:8655153,
CC       ECO:0000269|PubMed:8777804, ECO:0000269|PubMed:9040744}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Dejerine-Sottas syndrome (DSS) [MIM:145900]: A severe
CC       degenerating neuropathy of the demyelinating Charcot-Marie-Tooth
CC       disease category, with onset by age 2 years. Characterized by motor and
CC       sensory neuropathy with very slow nerve conduction velocities,
CC       increased cerebrospinal fluid protein concentrations, hypertrophic
CC       nerve changes, delayed age of walking as well as areflexia. There are
CC       both autosomal dominant and autosomal recessive forms of Dejerine-
CC       Sottas syndrome. {ECO:0000269|PubMed:10211478,
CC       ECO:0000269|PubMed:10663978, ECO:0000269|PubMed:11438991,
CC       ECO:0000269|PubMed:12090401, ECO:0000269|PubMed:7675244,
CC       ECO:0000269|PubMed:7728152, ECO:0000269|PubMed:8252046,
CC       ECO:0000269|PubMed:8275092, ECO:0000269|PubMed:8995589,
CC       ECO:0000269|PubMed:9004143, ECO:0000269|PubMed:9055797,
CC       ECO:0000269|PubMed:9187667, ECO:0000269|PubMed:9452053,
CC       ECO:0000269|PubMed:9544841, ECO:0000269|PubMed:9585367,
CC       ECO:0000269|PubMed:9633821}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Hereditary neuropathy with liability to pressure palsies
CC       (HNPP) [MIM:162500]: A neurologic disorder characterized by transient
CC       episodes of decreased perception or peripheral nerve palsies after
CC       slight traction, compression or minor traumas.
CC       {ECO:0000269|PubMed:12796555, ECO:0000269|PubMed:15205993,
CC       ECO:0000269|PubMed:9748013}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Charcot-Marie-Tooth disease 1E (CMT1E) [MIM:118300]: An
CC       autosomal dominant form of Charcot-Marie-Tooth disease characterized by
CC       the association of sensorineural hearing loss with peripheral
CC       demyelinating neuropathy. {ECO:0000269|PubMed:10330345,
CC       ECO:0000269|PubMed:11835375, ECO:0000269|PubMed:12578939,
CC       ECO:0000269|PubMed:15099592}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Inflammatory demyelinating polyneuropathy (IDP) [MIM:139393]:
CC       Putative autoimmune disorder presenting in an acute (AIDP) or chronic
CC       form (CIDP). The acute form is also known as Guillain-Barre syndrome.
CC       {ECO:0000269|PubMed:12439896}. Note=The disease may be caused by
CC       variants affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the PMP-22/EMP/MP20 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Inherited peripheral neuropathies mutation db;
CC       URL="https://uantwerpen.vib.be/CMTMutations";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M94048; AAA36457.1; -; mRNA.
DR   EMBL; D11428; BAA01995.1; -; mRNA.
DR   EMBL; S61788; AAB26811.1; -; mRNA.
DR   EMBL; L03203; AAA58495.1; -; mRNA.
DR   EMBL; BC019040; AAH19040.2; -; mRNA.
DR   EMBL; X65968; CAA46781.1; -; mRNA.
DR   CCDS; CCDS11168.1; -.
DR   PIR; JN0503; JN0503.
DR   RefSeq; NP_000295.1; NM_000304.3.
DR   RefSeq; NP_001268384.1; NM_001281455.1.
DR   RefSeq; NP_001268385.1; NM_001281456.1.
DR   RefSeq; NP_696996.1; NM_153321.2.
DR   RefSeq; NP_696997.1; NM_153322.2.
DR   BMRB; Q01453; -.
DR   BioGRID; 111389; 63.
DR   ELM; Q01453; -.
DR   IntAct; Q01453; 61.
DR   STRING; 9606.ENSP00000484631; -.
DR   ChEMBL; CHEMBL1293298; -.
DR   TCDB; 1.H.1.2.2; the claudin tight junction (claudin1) family.
DR   GlyGen; Q01453; 1 site.
DR   iPTMnet; Q01453; -.
DR   PhosphoSitePlus; Q01453; -.
DR   SwissPalm; Q01453; -.
DR   BioMuta; PMP22; -.
DR   DMDM; 266803; -.
DR   MassIVE; Q01453; -.
DR   PaxDb; Q01453; -.
DR   PeptideAtlas; Q01453; -.
DR   PRIDE; Q01453; -.
DR   ProteomicsDB; 57955; -.
DR   Antibodypedia; 13113; 391 antibodies.
DR   DNASU; 5376; -.
DR   Ensembl; ENST00000312280; ENSP00000308937; ENSG00000109099.
DR   Ensembl; ENST00000612492; ENSP00000484631; ENSG00000109099.
DR   Ensembl; ENST00000674651; ENSP00000501727; ENSG00000109099.
DR   Ensembl; ENST00000674673; ENSP00000501804; ENSG00000109099.
DR   Ensembl; ENST00000674868; ENSP00000502835; ENSG00000109099.
DR   Ensembl; ENST00000675350; ENSP00000501557; ENSG00000109099.
DR   Ensembl; ENST00000675808; ENSP00000502310; ENSG00000109099.
DR   Ensembl; ENST00000675819; ENSP00000502018; ENSG00000109099.
DR   Ensembl; ENST00000675950; ENSP00000501546; ENSG00000109099.
DR   Ensembl; ENST00000676221; ENSP00000502601; ENSG00000109099.
DR   GeneID; 5376; -.
DR   KEGG; hsa:5376; -.
DR   CTD; 5376; -.
DR   DisGeNET; 5376; -.
DR   GeneCards; PMP22; -.
DR   GeneReviews; PMP22; -.
DR   HGNC; HGNC:9118; PMP22.
DR   HPA; ENSG00000109099; Low tissue specificity.
DR   MalaCards; PMP22; -.
DR   MIM; 118220; phenotype.
DR   MIM; 118300; phenotype.
DR   MIM; 139393; phenotype.
DR   MIM; 145900; phenotype.
DR   MIM; 162500; phenotype.
DR   MIM; 601097; gene.
DR   neXtProt; NX_Q01453; -.
DR   OpenTargets; ENSG00000109099; -.
DR   Orphanet; 98916; Acute inflammatory demyelinating polyradiculoneuropathy.
DR   Orphanet; 101081; Charcot-Marie-Tooth disease type 1A.
DR   Orphanet; 90658; Charcot-Marie-Tooth disease type 1E.
DR   Orphanet; 64748; Dejerine-Sottas syndrome.
DR   Orphanet; 640; Hereditary neuropathy with liability to pressure palsies.
DR   Orphanet; 3115; Roussy-Levy syndrome.
DR   PharmGKB; PA33444; -.
DR   VEuPathDB; HostDB:ENSG00000109099.13; -.
DR   eggNOG; ENOG502S0F5; Eukaryota.
DR   GeneTree; ENSGT00910000146507; -.
DR   HOGENOM; CLU_138632_1_0_1; -.
DR   InParanoid; Q01453; -.
DR   OMA; VRHTDWH; -.
DR   OrthoDB; 539311at2759; -.
DR   PhylomeDB; Q01453; -.
DR   TreeFam; TF330414; -.
DR   PathwayCommons; Q01453; -.
DR   Reactome; R-HSA-9619665; EGR2 and SOX10-mediated initiation of Schwann cell myelination.
DR   SIGNOR; Q01453; -.
DR   BioGRID-ORCS; 5376; 8 hits in 1000 CRISPR screens.
DR   ChiTaRS; PMP22; human.
DR   GeneWiki; Peripheral_myelin_protein_22; -.
DR   GenomeRNAi; 5376; -.
DR   Pharos; Q01453; Tbio.
DR   PRO; PR:Q01453; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q01453; protein.
DR   Bgee; ENSG00000109099; Expressed in trigeminal ganglion and 250 other tissues.
DR   ExpressionAtlas; Q01453; baseline and differential.
DR   Genevisible; Q01453; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0045202; C:synapse; IEA:GOC.
DR   GO; GO:0032060; P:bleb assembly; IDA:UniProtKB.
DR   GO; GO:0008219; P:cell death; IDA:UniProtKB.
DR   GO; GO:0007268; P:chemical synaptic transmission; TAS:ProtInc.
DR   GO; GO:0032288; P:myelin assembly; IBA:GO_Central.
DR   GO; GO:0007399; P:nervous system development; TAS:Reactome.
DR   GO; GO:0007422; P:peripheral nervous system development; TAS:ProtInc.
DR   InterPro; IPR003936; PMP22.
DR   InterPro; IPR004031; PMP22/EMP/MP20/Claudin.
DR   InterPro; IPR004032; PMP22_EMP_MP20.
DR   PANTHER; PTHR10671:SF7; PTHR10671:SF7; 1.
DR   Pfam; PF00822; PMP22_Claudin; 1.
DR   PRINTS; PR01453; EPMEMFAMILY.
DR   PRINTS; PR01458; PMYELIN22.
DR   PROSITE; PS01221; PMP22_1; 1.
DR   PROSITE; PS01222; PMP22_2; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Charcot-Marie-Tooth disease; Deafness;
KW   Dejerine-Sottas syndrome; Disease variant; Glycoprotein; Membrane;
KW   Neurodegeneration; Neuropathy; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..160
FT                   /note="Peripheral myelin protein 22"
FT                   /id="PRO_0000164650"
FT   TOPO_DOM        1
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        2..31
FT                   /note="Helical"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        32..64
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        65..91
FT                   /note="Helical"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        92..95
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        96..119
FT                   /note="Helical"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        120..133
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        134..156
FT                   /note="Helical"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        157..160
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        41
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VARIANT         12
FT                   /note="H -> Q (in DSS; dbSNP:rs104894622)"
FT                   /evidence="ECO:0000269|PubMed:7728152"
FT                   /id="VAR_006359"
FT   VARIANT         16
FT                   /note="L -> P (in CMT1A and DSS; dbSNP:rs104894617)"
FT                   /evidence="ECO:0000269|PubMed:12090401,
FT                   ECO:0000269|PubMed:1303281"
FT                   /id="VAR_006360"
FT   VARIANT         19
FT                   /note="L -> P (in DSS)"
FT                   /id="VAR_006361"
FT   VARIANT         22
FT                   /note="S -> F (in HNPP and CMT1A; dbSNP:rs104894625)"
FT                   /evidence="ECO:0000269|PubMed:15205993"
FT                   /id="VAR_029960"
FT   VARIANT         23
FT                   /note="T -> R (in CMT1E; dbSNP:rs906563423)"
FT                   /evidence="ECO:0000269|PubMed:15099592"
FT                   /id="VAR_029961"
FT   VARIANT         25..26
FT                   /note="Missing (in CMT1A)"
FT                   /evidence="ECO:0000269|PubMed:10737979"
FT                   /id="VAR_029962"
FT   VARIANT         28
FT                   /note="W -> R (in CMT1E; dbSNP:rs104894626)"
FT                   /evidence="ECO:0000269|PubMed:11835375"
FT                   /id="VAR_029963"
FT   VARIANT         30
FT                   /note="V -> M (in HNPP; dbSNP:rs377335295)"
FT                   /evidence="ECO:0000269|PubMed:9748013"
FT                   /id="VAR_009659"
FT   VARIANT         37
FT                   /note="D -> V (in CMT1A; with focally folded myelin
FT                   sheaths; dbSNP:rs104894627)"
FT                   /evidence="ECO:0000269|PubMed:10489052"
FT                   /id="VAR_009660"
FT   VARIANT         65
FT                   /note="V -> F (in CMT1A)"
FT                   /evidence="ECO:0000269|PubMed:12497641"
FT                   /id="VAR_029964"
FT   VARIANT         67
FT                   /note="A -> P (in CMT1E; dbSNP:rs104894623)"
FT                   /evidence="ECO:0000269|PubMed:10330345"
FT                   /id="VAR_009661"
FT   VARIANT         67
FT                   /note="A -> T (in HNPP; dbSNP:rs104894623)"
FT                   /evidence="ECO:0000269|PubMed:12796555"
FT                   /id="VAR_029965"
FT   VARIANT         69
FT                   /note="M -> K (in DSS; dbSNP:rs104894620)"
FT                   /evidence="ECO:0000269|PubMed:8252046,
FT                   ECO:0000269|PubMed:8275092"
FT                   /id="VAR_006362"
FT   VARIANT         71
FT                   /note="L -> P (in DSS)"
FT                   /evidence="ECO:0000269|PubMed:11835375"
FT                   /id="VAR_029966"
FT   VARIANT         72
FT                   /note="S -> L (in DSS and CMT1A; dbSNP:rs104894621)"
FT                   /evidence="ECO:0000269|PubMed:11140841,
FT                   ECO:0000269|PubMed:11438991, ECO:0000269|PubMed:12402337,
FT                   ECO:0000269|PubMed:7675244, ECO:0000269|PubMed:8252046,
FT                   ECO:0000269|PubMed:8275092, ECO:0000269|PubMed:9004143,
FT                   ECO:0000269|PubMed:9585367"
FT                   /id="VAR_006363"
FT   VARIANT         72
FT                   /note="S -> P (in DSS)"
FT                   /id="VAR_006364"
FT   VARIANT         72
FT                   /note="S -> W (in DSS)"
FT                   /evidence="ECO:0000269|PubMed:9055797"
FT                   /id="VAR_006365"
FT   VARIANT         76
FT                   /note="S -> I (in DSS)"
FT                   /evidence="ECO:0000269|PubMed:9055797"
FT                   /id="VAR_006366"
FT   VARIANT         79
FT                   /note="S -> C (in CMT1A; dbSNP:rs104894618)"
FT                   /evidence="ECO:0000269|PubMed:8252046,
FT                   ECO:0000269|PubMed:8510709"
FT                   /id="VAR_006367"
FT   VARIANT         79
FT                   /note="S -> P (in DSS)"
FT                   /evidence="ECO:0000269|PubMed:9452053"
FT                   /id="VAR_006368"
FT   VARIANT         80
FT                   /note="L -> P (in DSS)"
FT                   /evidence="ECO:0000269|PubMed:9055797"
FT                   /id="VAR_006369"
FT   VARIANT         80
FT                   /note="L -> R (in DSS)"
FT                   /evidence="ECO:0000269|PubMed:12090401"
FT                   /id="VAR_029967"
FT   VARIANT         84
FT                   /note="Missing (in DSS)"
FT                   /evidence="ECO:0000269|PubMed:9633821"
FT                   /id="VAR_006370"
FT   VARIANT         93
FT                   /note="G -> R (in CMT1A; dbSNP:rs778693173)"
FT                   /evidence="ECO:0000269|PubMed:8777804"
FT                   /id="VAR_009662"
FT   VARIANT         100
FT                   /note="G -> E (in DSS)"
FT                   /evidence="ECO:0000269|PubMed:9585367"
FT                   /id="VAR_006371"
FT   VARIANT         100
FT                   /note="G -> R (in DSS)"
FT                   /evidence="ECO:0000269|PubMed:9187667"
FT                   /id="VAR_006372"
FT   VARIANT         105
FT                   /note="L -> R (in CMT1A and DSS)"
FT                   /evidence="ECO:0000269|PubMed:12090401,
FT                   ECO:0000269|PubMed:8615087"
FT                   /id="VAR_006373"
FT   VARIANT         107
FT                   /note="G -> V (in CMT1A)"
FT                   /evidence="ECO:0000269|PubMed:9040744"
FT                   /id="VAR_006374"
FT   VARIANT         109
FT                   /note="C -> R (in DSS)"
FT                   /evidence="ECO:0000269|PubMed:11438991"
FT                   /id="VAR_029968"
FT   VARIANT         115..118
FT                   /note="Missing (in CMT1E)"
FT                   /evidence="ECO:0000269|PubMed:12578939"
FT                   /id="VAR_029969"
FT   VARIANT         118
FT                   /note="T -> M (in CMT1A; dbSNP:rs104894619)"
FT                   /evidence="ECO:0000269|PubMed:10737979,
FT                   ECO:0000269|PubMed:16437560, ECO:0000269|PubMed:8252046,
FT                   ECO:0000269|PubMed:8988161, ECO:0000269|PubMed:9452099"
FT                   /id="VAR_006375"
FT   VARIANT         137
FT                   /note="I -> V (in dbSNP:rs755551524)"
FT                   /id="VAR_006376"
FT   VARIANT         147
FT                   /note="L -> R (in CMT1A)"
FT                   /evidence="ECO:0000269|PubMed:10737979,
FT                   ECO:0000269|PubMed:8655153"
FT                   /id="VAR_006377"
FT   VARIANT         149
FT                   /note="S -> R (in DSS; dbSNP:rs775019409)"
FT                   /evidence="ECO:0000269|PubMed:10663978"
FT                   /id="VAR_029970"
FT   VARIANT         150
FT                   /note="G -> C (in DSS; dbSNP:rs104894624)"
FT                   /evidence="ECO:0000269|PubMed:9544841"
FT                   /id="VAR_006378"
FT   VARIANT         150
FT                   /note="G -> D (in DSS; dbSNP:rs879253954)"
FT                   /evidence="ECO:0000269|PubMed:8995589"
FT                   /id="VAR_006379"
FT   VARIANT         157
FT                   /note="R -> G (in dbSNP:rs28936682)"
FT                   /evidence="ECO:0000269|PubMed:10632107"
FT                   /id="VAR_009663"
FT   VARIANT         157
FT                   /note="R -> W (in DSS; dbSNP:rs28936682)"
FT                   /evidence="ECO:0000269|PubMed:10211478"
FT                   /id="VAR_009664"
SQ   SEQUENCE   160 AA;  17891 MW;  7ECF7F91BED0CF9D CRC64;
     MLLLLLSIIV LHVAVLVLLF VSTIVSQWIV GNGHATDLWQ NCSTSSSGNV HHCFSSSPNE
     WLQSVQATMI LSIIFSILSL FLFFCQLFTL TKGGRFYITG IFQILAGLCV MSAAAIYTVR
     HPEWHLNSDY SYGFAYILAW VAFPLALLSG VIYVILRKRE
//
